googlemarker
Open An Account
Secure With Us
Refer a Friend
Trade on Mobile

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 582597.92 Face Value (Rs.) : 2 House : Cipla
BSE722.558.7 (+1.22 %)
PREV CLOSE (Rs.) 713.85
OPEN PRICE (Rs.) 719.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 178059
TODAY'S LOW / HIGH (Rs.)716.00 729.90
52 WK LOW / HIGH (Rs.)356.75 734
NSE722.158.3 (+1.16 %)
PREV CLOSE( Rs. ) 713.85
OPEN PRICE (Rs.) 720.80
BID PRICE (QTY) 722.15 (2101)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5263247
TODAY'S LOW / HIGH(Rs.) 716.00 729.95
52 WK LOW / HIGH (Rs.)355.3 734.2
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
1286.07
Dividend Yield(%)
0.55
TTM EPS (Rs.)
28.75
P/E Ratio
25.13
Book Value (Rs.)
215.84
Face Value (Rs.)
2
MCap (Rs. in Mn)
582597.92
Price/Earning (TTM)
19.97
Price/Sales (TTM)
4.77
Price/Book (MRQ)
3.35
PAT Margin (%)
14.48
ROCE (%)
16.69
Incorporation Year : 17-08 1935

Management Info :

Y K Hamied - Chairman Umang Vohra - Managing Director

Registered Office :

Address : Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower Parel,
Mumbai,
Maharashtra-400013

Phone : 022-24826000 / 022-24826951

Website : www.cipla.com

Registrars Details :

K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX
27Jul Cipla, Precision Camshafts and Jenburk
Cipla has been granted regulatory approval by the Drug Controller Genera..
27Jul Cipla gains on getting DCGI’s nod to l
Cipla is currently trading at Rs. 669.10, up by 3.60 points or 0.54% fro..
25Jul Cipla gets DCGI’s nod to launch Ciplen
Cipla has been granted regulatory approval by the Drug Controller Genera..
QTR Mar 20 ANNUAL 20
Net Profit6045.723181.7
Gross Profit 7085.5 29643.1
Operating Profit 8782.1 36001.4
Net Sales 31334.4 126591.5
Rs. in Millions
Valiant Organics (BSE)
img  2165.00 (9.69%)
M.Cap (Rs. in Cr)2630.31
Aarti Drugs (BSE)
img  1882.45 (8.68%)
M.Cap (Rs. in Cr)4386.11
Sanofi India (BSE)
img  8283.35 (0.98%)
M.Cap (Rs. in Cr)19077.07
Strides Pharma Scien (BSE)
img  534.50 (14.22%)
M.Cap (Rs. in Cr)4788.76
PROMOTERS
36.68%
NON-INSTITUTION
23.4%
MUTUAL FUNDS/UTI
16.29%
FI/BANKS/INSURANCE
4.78%
FII
0.01%
GOVERNMENT
0%
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.....Issued in the interest of investors.  |  No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. |  KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Dear Client, Pursuant to SEBI regulation, update your KYC details through KRA form with supporting documents at earliest to complete KYC-KRA requirement. If already submitted, kindly ignore. For any information, in this regard, please contact to our KYC Department on 022-66556772/73/74 or email at kyc@satco.co.in.
  • NSE - INZ000198838  | 
  • BSE- INZ000198838  | 
  • MCX- INZ000198838  | 
  • NCDEX- INZ000198838  | 
  • CDSL – IN-DP-CDSL-727-2014  | 
  • PMS - INP000003492  | 
  • RESEARCH – INH000002343
  • © Copyright 2015. SATCO CAPITAL MARKETS LTD. || Designed Developed & Content Powered By Accord Fintech Pvt.Ltd.
VISIT COUNT     1842360